Home NDC 50580-833 TYLENOL PM
Product NDC 50580-833
11-digit product format 505800833
Labeler code 50580
Product ID 50580-833_5def488c-5857-81d7-e063-6294a90ac270
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen and Diphenhydramine Hydrochloride
Dosage form SOLUTION
Route ORAL
Labeler Kenvue Brands LLC
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2018-06-25
Substance ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Active strength 1000; 50 mg/30mL; mg/30mL
Pharmacologic classes Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 20 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50580-833-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50580-833-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50580-833-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50580-833-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50580-833-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50580-833-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50580-833-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50580-833-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50580-833-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 50580-833-01 ad56d346431e…cc804d4bbf1e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base TYLENOL PM
Brand name suffix Extra Strength
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACETAMINOPHEN 1000 mg/30mL DIPHENHYDRAMINE HYDROCHLORIDE 50 mg/30mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 362O9ITL9D Internal UNII lookup TC2D6JAD40 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1092373 Internal RxNorm lookup 1092375 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 65 of 77 · 1,530 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aspirin ASPIRIN AAA Pharmaceutical, Inc. 609948d6-0f20-4d0c-adc0-6ae72a4f2b7a 2024-06-13 Warnings Exact identifier application number: M013 Aspirin ASPIRIN AAA Pharmaceutical, Inc. 3f73a359-59d7-47bb-872e-914b0db719af 2024-06-13 Warnings Exact identifier application number: M013 topcare infants pain and fever ACETAMINOPHEN Topco Associates LLC f1e940ef-3cf0-4a5c-8158-156d0e5a680d 2024-06-13 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Trifecta Pharmaceuticals USA LLC 026bf664-d598-73de-e063-6394a90a9206 2024-06-12 Warnings Exact identifier application number: M013 Regular Strength Pain Relief ACETAMINOPHEN NuCare Pharmaceuticals,Inc. 7c73fc75-af9b-177c-e053-2a91aa0ada56 2024-06-12 Warnings Exact identifier application number: M013 Low Dose Aspirin ASPIRIN Topco Associates 4a6a1dbb-c813-42fd-9bb8-497aec339466 2024-06-11 Warnings Exact identifier application number: M013 Headache Relief Extra Strength ACETAMINOPHEN, ASPIRIN, CAFFEINE The Kroger Co. fa234639-caf8-4c52-9ffe-f1c0c057ee5b 2024-06-10 Warnings Exact identifier application number: M013 Headache Relief Extra Strength ACETAMINOPHEN, ASPIRIN, CAFFEINE The Kroger Co. bc18590d-6481-4efe-8a3b-974f7543b754 2024-06-10 Warnings Exact identifier application number: M013 ASPIRIN ASPIRIN H-E-B 085b35db-62e4-38db-e063-6394a90a9763 2024-06-07 Warnings Exact identifier application number: M013 pain and fever ACETAMINOPHEN Meijer Distribution Inc cbfa2a25-f1e7-491e-9b67-ff2f4ba0b6cf 2024-06-07 Warnings Exact identifier application number: M013 Headache Relief Extra Strength ACETAMINOPHEN, ASPIRIN, CAFFEINE The Kroger Co. 5691ac45-5732-412e-abb8-2bfaac59160e 2024-06-07 Warnings Exact identifier application number: M013 Cafiaspirina Rapid Headache Relief ASPIRIN, CAFFEINE Belmora LLC d890acec-6528-4fb7-8d59-6c572a3f0786 2024-06-07 Warnings Exact identifier application number: M013 Headache Relief Extra Strength ACETAMINOPHEN, ASPIRIN, CAFFEINE TARGET Corporation 611bc1ce-460a-44a3-8e2d-b28a399d9a44 2024-06-06 Warnings Exact identifier application number: M013 CareOne Childrens Acetaminophen ACETAMINOPHEN American Sales Company 126ee71a-c408-415b-9a43-502337a91055 2024-06-05 Warnings Exact identifier application number: M013 Tylenol Extra Strength ACETAMINOPHEN A-S Medication Solutions 85294a70-3233-4ba5-bc36-ee3f2964aebf 2024-06-05 Warnings Exact identifier application number: M013 Aspirin 81mg ASPIRIN 81MG Lodaat LLC 6a35f38c-a240-4f8c-9a8e-8d283b67b55b 2024-06-04 Warnings Exact identifier application number: M013 Aspirin 81mg ASPIRIN 81MG Lodaat LLC 1ec12f4b-de05-4990-a7b7-f82d867361de 2024-06-04 Warnings Exact identifier application number: M013 CareOne Infants Acetaminophen ACETAMINOPHEN American Sales Company 0a28a4f1-d947-489b-be28-36ba10b581cf 2024-06-01 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Bryant Ranch Prepack 77fb237f-28b5-486b-b9ef-cb324d5cc0bd 2024-05-30 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Bryant Ranch Prepack b5053cf5-209d-4106-afc2-cf9af85f4a69 2024-05-29 Warnings Exact identifier application number: M013
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50580-833-01 50580083301 240 mL in 1 BOTTLE (50580-833-01) 240 ml 2018-06-25 0000-00-00 No No Current